Genexa, the First-Ever Clean Medicine Brand, Releases State of the Sick Day Study, Revealing What Parents Actually Face When Their Kids Get Sick
New Study from Genexa Outlines the Increasing Role that Digital Spaces Play for Parenting Advice ATLANTA–(BUSINESS WIRE)–Genexa, the first clean medicine... Read more.
AM Best Revises Outlooks to Positive for CTBC Insurance Company Ltd
HONG KONG–(BUSINESS WIRE)–#insurance—AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of B++... Read more.
Aras Announces Theme, Agenda and Guest Keynote for Annual Conference
Cuebric CEO Pinar Seyhan Demirdag to deliver keynote on AI’s role in redefining creativity, innovation and the next era of PLM ANDOVER, Mass.–(BUSINESS WIRE)–#DigitalThread—Aras,... Read more.
Vector Capital Originates $50 Million Loan for Sylvan’s Strategic Combination with Andy J. Egan Co., Inc.
Supports First Investment for E-3 Tech’s Flagship Multi-Trade Construction Platform SAN FRANCISCO–(BUSINESS WIRE)–Vector Capital Management, L.P.’s... Read more.
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #animalhealth—Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 37th Annual Healthcare Conference... Read more.
Qlik Delivers Secure, Open Access to Trusted Data in Any Tool
Open APIs, field auto-documentation, and faster quality rules arrive in Qlik Talend Cloud; Data Stewardship Early Access is now open. PHILADELPHIA–(BUSINESS... Read more.
Argan, Inc. to Announce Third Quarter Fiscal 2026 Results and Host Conference Call on Thursday, December 4, 2025
ARLINGTON, Va.–(BUSINESS WIRE)–Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its third quarter... Read more.
CrowdStrike to Participate in Upcoming Investor Conference
AUSTIN, Texas–(BUSINESS WIRE)–CrowdStrike Holdings, Inc. (Nasdaq: CRWD) today announced that it is scheduled to present at the following investor conference:... Read more.
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with NSCLC eligible for HER2-targeted therapy CARLSBAD, Calif.–(BUSINESS... Read more.
“All Genetic Diseases Could be Cured within a Decade”, Hears Dubai Future Forum
DUBAI, United Arab Emirates–(BUSINESS WIRE)–All known genetic diseases could be cured within the next decade thanks to major advances in gene editing,... Read more.